Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-signs-2-bln-agreement-with-quell-develop-cell-therapies-2023-06-09/
https://www.globenewswire.com/news-release/2023/06/09/2685293/0/en/Quell-Therapeutics-Signs-a-Collaboration-Exclusive-Option-and-License-Agreement-with-AstraZeneca-to-Develop-Manufacture-and-Commercialize-Engineered-Treg-Cell-Therapies-for-Autoimm.html
https://www.prnewswire.com/news-releases/quell-therapeutics-to-present-at-upcoming-investor-conferences-in-2022-301685112.html
https://www.prnewswire.com/news-releases/quell-therapeutics-appoints-luke-devey-bmbch-phd-as-chief-medical-officer-301682975.html
http://www.pharmafile.com/news/626274/quell-therapeutics-and-cellistic-collaborate-develop-t-regulatory-cell-therapy-platform
https://www.fiercebiotech.com/biotech/next-gen-car-player-quell-therapeutics-drives-into-fast-lane-major-156m-round
https://www.prnewswire.com/news-releases/quell-therapeutics-raises-156-million-in-oversubscribed-series-b-financing-to-advance-its-pioneering-multi-modular-engineered-t-regulatory-treg-cell-therapy-pipeline-and-platform-301432188.html
https://www.prnewswire.com/news-releases/quell-therapeutics-granted-cta-approval-to-begin-first-clinical-trial-with-a-multi-modular-engineered-treg-cell-therapy-301409320.html
https://www.prnewswire.com/news-releases/quell-therapeutics-presents-new-data-demonstrating-the-ability-of-its-proprietary-phenotype-lock-technology-to-enhance-the-safety-stability-and-efficacy-of-engineered-treg-therapies-301402542.html